• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care
    Get the next $SEM alert in real time by email

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately.

    Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilitation hospitals and the expansive growth of both divisions nationwide.  Over his 17 years with the company, Mr. Mullin has held executive leadership roles of increasing responsibility including executive vice president from 2020-2023, president of specialty hospitals from 2018-2020, and chief operating officer of specialty hospitals from 2016-2018.  Prior to his divisional appointments, Mr. Mullin held a variety of leadership positions in the Critical Illness Recovery Hospital Division, including senior vice president of business and market development, and regional vice president.  Earlier in his Select Medical career, Mr. Mullin held operational positions at the hospital level in the division.

    Mr. Chernow has been appointed vice chairman of the board after serving as the company's chief executive officer since 2014.  Previously, he served as president and chief executive officer from 2014-2023 and as president and chief strategy officer from 2010-2014.  Prior to Mr. Chernow's corporate officer posts, he joined the board of directors of Select Medical Corporation in 2002 and was an independent director of that company for nearly a decade.

    Mr. Saich, who has held the post of co-president since 2023, will serve as the sole president of Select Medical.  He will retain oversight of outpatient rehabilitation and shared services operations while taking on expanded responsibilities across the organization.  Previously, Mr. Saich served as executive vice president and chief administrative officer from 2018-2023 and held a variety of senior human resources leadership positions spanning his 27 years with the company.

    Mr. Duggan, a 25-year Select Medical veteran, has been appointed executive vice president, general counsel and secretary after serving as executive vice president and deputy general counsel since 2023. Previously, Mr. Duggan held the posts of senior vice president and senior counsel from 2007-2023, vice president and senior counsel from 2002-2007, and associate counsel from 2000-2002.

    Michael E. Tarvin has served as senior executive vice president, general counsel and secretary since 2023, as executive vice president, general counsel and secretary from 2007-2023, as senior vice president, general counsel and secretary from 1999-2007, and as vice president, general counsel and secretary from 1997-1999.  Mr. Tarvin will transition to his new post as senior executive vice president of legal services.

    "Select Medical has always placed a high priority on the development and growth of its people as a means to drive the future success of the company," said Select Medical Co-Founder and Executive Chairman Robert A. Ortenzio.  "The appointments of these long-time veterans with impeccable track records underscores our commitment to our values, vision and mission.  I could not be more proud to see Select Medical's succession planning process working with the appointment of these next generation leaders, each with decades of experience at the company.  I look forward to continuing to work closely with these top-notch executives as we execute against an aggressive growth strategy that provides patients with access to world-class post-acute care across the country and delivers value to our stockholders."

    About Select Medical

    Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on number of facilities. As of June 30, 2025, Select Medical operated 104 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,919 outpatient rehabilitation clinics in 39 states and the District of Columbia. At June 30, 2025, Select Medical had operations in 40 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

    Media inquiries:

    Shelly Eckenroth

    [email protected]

    717-920-4035

    Investor inquiries:

    Joel T. Veit

    [email protected]

    717-972-1100

    Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html

    SOURCE Select Medical Holdings Corporation

    Get the next $SEM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEM

    DatePrice TargetRatingAnalyst
    4/16/2025$25.00Outperform
    Mizuho
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    11/25/2024Buy → Hold
    The Benchmark Company
    8/20/2024$42.00Buy
    BofA Securities
    3/7/2022$47.00 → $42.00Outperform
    RBC Capital
    1/18/2022$40.00 → $35.00Buy
    B of A Securities
    1/18/2022$50.00 → $47.00Outperform
    RBC Capital
    8/10/2021$37.00 → $39.00Neutral
    Credit Suisse
    More analyst ratings

    $SEM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

    MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar

    7/31/25 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Second Quarter 2025 Results on Thursday, July 31, 2025

    MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene

    6/27/25 4:15:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Select Medical with a new price target

    Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00

    4/16/25 9:09:30 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00

    2/24/25 7:15:26 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical downgraded by The Benchmark Company

    The Benchmark Company downgraded Select Medical from Buy to Hold

    11/25/24 7:51:28 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Duggan John F. claimed ownership of 149,575 shares (SEC Form 3)

    3 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    9/2/25 5:33:17 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    EXECUTIVE VICE PRESIDENT Saich John A. covered exercise/tax liability with 21,745 shares, decreasing direct ownership by 3% to 736,412 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    8/4/25 4:22:25 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    CO-PRESIDENT Mullin Thomas P covered exercise/tax liability with 22,045 shares, decreasing direct ownership by 5% to 391,709 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    8/4/25 4:21:29 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    SEC Filings

    View All

    Select Medical Holdings Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    9/2/25 4:21:49 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    8/4/25 8:00:54 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    7/31/25 4:38:35 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    5/6/25 6:21:53 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Financials

    Live finance-specific insights

    View All

    Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

    MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar

    7/31/25 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Second Quarter 2025 Results on Thursday, July 31, 2025

    MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene

    6/27/25 4:15:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2025 and Cash Dividend

    MECHANICSBURG, Pa., May 1, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. For the first quarter ended March 31, 2025, revenue increased 2.4% to $1,353.2 million, compared to $1,321.2 million for the same quarter, prior year. Income from continuing operations before other income and expense was $112.7 million for the first quarter ended March 31, 2025, compared to $118.5 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 21.5% to $74.7 million for the first quarter ended March 

    5/1/25 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/14/24 1:22:35 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:31 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:04 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Leadership Updates

    Live Leadership Updates

    View All

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

    MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021.  Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi

    11/2/21 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care